Five patients have so far been treated with Anocca’s in-house developed TCR-T cell therapy for pancreatic cancer, with the latest becoming the first patient in Sweden. The Södertälje-based company is ...

The US Food and Drug Administration (FDA) has approved a surgically implanted heart valve for children with a special feature: it can be expanded as the child grows.

After formerly obtaining a regulatory for patients over 18 years old, Hedia can now expand its support to pediatric care.

Despite meeting both primary endpoints in a Phase 3 trial of the obesity drug survodutide, Zealand Pharma’s shares fell sharply on Thursday.

Sanofi and Regeneron are stepping up their long-standing partnership. The companies are now investing in four new antibody ...

One in three Swedish infants have no detectable levels of a bacterium that helps support the developing immune system, according to a new Swedish study. The figure is notably high compared with ...

Swedish biotech company Empros Pharma is discontinuing its obesity drug programme. Difficulties in securing funding and ...

Swedish biotech company AnaCardio has raised €62.5 million, equivalent to more than SEK 700 million, in its largest funding round to date. “It’s a big day for us,” says Patrik Strömberg, the company’s ...

After years of success with the injection based Wegovy, Novo has released it in pill form in a wide range of countries – but ...

A successful Phase III trial in age-related macular degeneration sent shares in US-based Kodiak Sciences soaring on Monday.

Cinclus Pharma, which is developing new therapies for acid-related diseases, has now completed all planned patient visits in ...

MEMBER ANNOUNCEMENT - Many innovative therapies and medical technologies face the same challenge: you know a clinical study ...